Allarity Therapeutics, a Phase 2-stage biopharmaceutical with activities in Copenhagen and Boston, has formally enrolled its first patient in its newly launched Phase 2 trial
Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).
Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...
Reckitt, the world's leading consumer health and hygiene company, associated with the Public Health Foundation of India
A step in the direction of streamlining and simplification of the export procedure for India's traditional medicinal industry, the Ministry of Commerce and Industry
India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...
Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...
Indian Technology Development Board (TDB), which operates under Department of Science and Technology (DST), has provided finance support to excipient producer of pharmaceuticals
The Indian Pharmacopoeia (IP) was refurbished to consider as a gold standard and taken to the extent of benchmarking by the Indian Pharmacopoeia Commission
Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...